Page 2 - Cingulate Inc News Today

Shares of Skechers U.S.A., Inc. (NYSE:SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial re...

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build

Stimulants, amphetamines, and methylphenidates are currently the first-line treatment for moderate to severe attention-deficit/hyperactivity disorder (ADHD) across the seven major global markets; France, Germany, Italy, Spain, the UK, the US, and Japan.

Cingulate (NASDAQ:CING – Free Report) had its price objective boosted by HC Wainwright to $8.00 in a research note released on Friday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several other analysts also recently commented on CING. Laidlaw downgraded shares of Cingulate from a buy rating to a hold […]

The CNN Money Fear and Greed index remained in the "Extreme Greed" zone on Thursday. U.S. stocks closed mostly higher on Thursday, with the S&P 500 ending the session just 0.3% down from its record closing level, notched on Jan. 3, 2022. Traders see a 74.1% chance that the Fed will cut rates by 25 basis points in March.

Shares of Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) rose sharply in today’s pre-market trading session. Titan Pharmaceuticals said its Boa...

U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining around 10 points on Friday. Following the market opening Friday, the Dow traded up 0.03% to 37,723.19 while the NASDAQ rose 0.02% to 15,098.01. The S&P 500 also rose, gaining, 0.05% to 4,785.65.

Shares of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose sharply in today’s pre-market trading session. Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split. Titan Pharmaceuticals shares jumped 15.2% to $0.38 in pre-market trading.

Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.

CING | Complete Cingulate Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.